PROCARCINOGEN ACTIVATION BY CYTOCHROME-P450 3A4 AND 3A5 EXPRESSED IN ESCHERICHIA-COLI AND BY HUMAN LIVER-MICROSOMES

被引:50
作者
YAMAZAKI, H
INUI, Y
WRIGHTON, SA
GUENGERICH, FP
SHIMADA, T
机构
[1] OSAKA PREFECTURAL INST PUBL HLTH,HIGASHINARI KU,OSAKA 537,JAPAN
[2] CTR ADULT DIS,HIGASHINARI KU,OSAKA 537,JAPAN
[3] ELI LILLY & CO,DEPT DRUG METAB & DISPOSIT,INDIANAPOLIS,IN 46285
[4] VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232
[5] VANDERBILT UNIV,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232
关键词
D O I
10.1093/carcin/16.9.2167
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies indicate that cytochrome P450 (P450) 3A4 plays important roles in the activation of procarcinogens such as aflatoxin B-1 and sterigmatocystin, as well as in the oxidation of a number of structurally diverse chemicals and endogenous compounds. Since P450 3A5 has been reported to be present at significant levels in liver microsomes in similar to 25% of human adults, we examined and compared the role of P450 3A4 and 3A5 in procarcinogen activation in humans. Immunoblot experiments with liver microsomes from 60 human samples suggested that 4/30 Japanese and 4/30 Caucasians contained considerable levels of P450 3A5, although P450 3A4 could be determined at relatively high levels in all of the human samples examined. Good correlation was observed between P450 3A4, but not P450 3A5, levels versus activation of aflatoxin B-1 and stergmatocystin in these human samples. Comparisons of the activation of procarcinogens in reconstituted monooxygenase systems containing modified P450 3A4 and 3A5 enzymes expressed in Escherichia coli were carried out in Salmonella typhimurium TA1535/pSK1002 or NM2009 tester strain for genotoxicity assay, and it was found that P450 3A4 had similar activities to or higher rates than P450 3A5 for the 24 procarcinogens tested.
引用
收藏
页码:2167 / 2170
页数:4
相关论文
共 30 条
[1]   EXPRESSION OF CYTOCHROME-P450-3A5 IN ESCHERICHIA-COLI - EFFECTS OF 5' MODIFICATION, PURIFICATION, SPECTRAL CHARACTERIZATION, RECONSTITUTION CONDITIONS, AND CATALYTIC ACTIVITIES [J].
GILLAM, EMJ ;
GUO, ZY ;
UENG, YF ;
YAMAZAKI, H ;
COCK, I ;
REILLY, PEB ;
HOOPER, WD ;
GUENGERICH, FP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 317 (02) :374-384
[2]   EXPRESSION OF MODIFIED HUMAN CYTOCHROME-P450 3A4 IN ESCHERICHIA-COLI AND PURIFICATION AND RECONSTITUTION OF THE ENZYME [J].
GILLAM, EMJ ;
BABA, T ;
KIM, BR ;
OHMORI, S ;
GUENGERICH, FP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 305 (01) :123-131
[3]   CDNA-EXPRESSED HUMAN CYTOCHROME-P450S - A NEW AGE OF MOLECULAR TOXICOLOGY AND HUMAN RISK ASSESSMENT [J].
GONZALEZ, FJ ;
CRESPI, CL ;
GELBOIN, HV .
MUTATION RESEARCH, 1991, 247 (01) :113-127
[4]  
Guengerich F. Peter, 1994, P1259
[5]   ESTIMATION OF ISOZYMES OF MICROSOMAL CYTOCHROME-P-450 IN RATS, RABBITS, AND HUMANS USING IMMUNOCHEMICAL STAINING COUPLED WITH SODIUM DODECYL-SULFATE POLYACRYLAMIDE-GEL ELECTROPHORESIS [J].
GUENGERICH, FP ;
WANG, P ;
DAVIDSON, NK .
BIOCHEMISTRY, 1982, 21 (07) :1698-1706
[6]  
GUENGERICH FP, 1989, ANNU REV PHARMACOL, V29, P241
[7]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407
[8]   ROLE OF HUMAN CYTOCHROME-P-450-IIE1 IN THE OXIDATION OF MANY LOW-MOLECULAR-WEIGHT CANCER SUSPECTS [J].
GUENGERICH, FP ;
KIM, DH ;
IWASAKI, M .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (02) :168-179
[9]  
Kaminsky L S, 1981, Methods Enzymol, V74 Pt C, P262
[10]   P450 AND HUMAN CANCER [J].
KAWAJIRI, K ;
FUJIIKURIYAMA, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (12) :1325-1335